Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 16, 2023, with respect to the financial statements of ORIC Pharmaceuticals, Inc., incorporated herein by reference.
/s/ KPMG LLP
San Diego, California
March 16, 2023
